Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Mereo BioPharma (MREO) Return on Equity (2023 - 2025)

Mereo BioPharma (MREO) has disclosed Return on Equity for 3 consecutive years, with 0.96% as the latest value for Q4 2025.

  • Quarterly Return on Equity fell 844.0% to 0.96% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 0.96% through Dec 2025, down 844.0% year-over-year, with the annual reading at 0.82% for FY2025, 5.0% down from the prior year.
  • Return on Equity for Q4 2025 was 0.96% at Mereo BioPharma, down from 0.83% in the prior quarter.
  • The five-year high for Return on Equity was 7.48% in Q4 2024, with the low at 15.17% in Q3 2024.
  • Average Return on Equity over 3 years is 1.15%, with a median of 0.61% recorded in 2024.
  • The sharpest move saw Return on Equity plummeted -1478bps in 2024, then surged 1435bps in 2025.
  • Over 3 years, Return on Equity stood at 0.58% in 2023, then skyrocketed by 1389bps to 7.48% in 2024, then crashed by -113bps to 0.96% in 2025.
  • According to Business Quant data, Return on Equity over the past three periods came in at 0.96%, 0.83%, and 0.87% for Q4 2025, Q3 2025, and Q2 2025 respectively.